2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)

Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029

Angiotensin-neprilysin inhibition versus enalapril in heart failure

McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

(1999) · The Lancet · doi:10.1016/s0140-6736(99)04440-2 · Cited by 5,129

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929

Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)

Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595

Telmisartan, ramipril, or both in patients at high risk for vascular events

(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502

Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure

Maisel, A. S., Krishnaswamy, P., Nowak, R. M., McCord, J., Hollander, J. E., Duc, P., Omland, T., Storrow, A. B., Abraham, W. T., Wu, A. H. B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020233 · Cited by 3,362

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108

Effect of carvedilol on survival in severe chronic heart failure

Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093

Clinical Practice Guidelines We Can Trust

Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927

Spironolactone for heart failure with preserved ejection fraction

Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400

The progression from hypertension to congestive heart failure

Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · PubMed · Cited by 2,144

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea

McEvoy, R. D., Antic, N. A., Heeley, E., Luo, Y., Ou, Q., Zhang, X., Mediano, O., Chen, R., Drager, L. F., Liu, Z., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606599 · Cited by 2,101

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083 · cited 1×

Irbesartan in patients with heart failure and preserved ejection fraction

Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860

Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure

Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Køber, L., Torp-Pedersen, C., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N. C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,773

Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., & Chang, P. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,665

Effect of carvedilol on survival in severe chronic heart failure

Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

Troughton, R. W., Frampton, C. M., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,376

Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study

Packer, M., Fowler, M. B., Roecker, E. B., Coats, A. J. S., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Staiger, C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035653.72855.bf · Cited by 1,364

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial

Williamson, J. D., Supiano, M. A., Applegate, W. B., Berlowitz, D. R., Campbell, R. C., Chertow, G. M., Fine, L. J., Haley, W. E., Hawfield, A. T., Ix, J. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.7050 · Cited by 1,261

Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

Packer, M., Poole-Wilson, P. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Rydén, L., Thygesen, K., & Uretsky, B. F. (1999) · Circulation · doi:10.1161/01.cir.100.23.2312 · Cited by 1,244 · cited 3×

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

Ponikowski, P., van Veldhuisen, D. J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T., Parkhomenko, A., Tavazzi, L., Levesque, V., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu385 · Cited by 1,242

Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure

Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051001 · Cited by 1,189

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Solomon, S. D., Zile, M., Pieske, B., Voors, A., Shah, A., Kraigher-Krainer, E., Shi, V., Bransford, T., Takeuchi, M., Gong, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61227-6 · Cited by 1,173

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial

Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., et al. (2013) · JAMA · doi:10.1001/jama.2013.2024 · Cited by 1,155

Plasma brain natriuretic peptide concentration: impact of age and gender

Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D. W., Bailey, K. R., & Burnett, J. C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02059-4 · Cited by 1,138

Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure

Cowie, M. R., Woehrle, H., Wegscheider, K., Angermann, C., d’Ortho, M.-P., Erdmann, E., Levy, P., Simonds, A. K., Somers, V. K., Zannad, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506459 · Cited by 1,107

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099

Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Pfeffer, M. A., Claggett, B., Assmann, S. F., Boineau, R., Anand, I. S., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., Gordeev, I., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013255 · Cited by 1,065

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059

Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease?

Creemers, E. E., Tijsen, A. J., & Pinto, Y. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.247452 · Cited by 1,009

Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea

Mueller, C., Scholer, A., Laule-Kilian, K., Martina, B., Schindler, C., Buser, P., Pfisterer, M., & Perruchoud, A. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031681 · Cited by 1,000

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008) · The Lancet · doi:10.1016/s0140-6736(08)61242-8 · Cited by 1,000

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

Xie, X., Atkins, E., Lv, J., Bennett, A., Neal, B., Ninomiya, T., Woodward, M., MacMahon, S., Turnbull, F., Hillis, G. S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00805-3 · Cited by 980

Finding What Works in Health Care: Standards for Systematic Reviews

Eden, J., Levit, L. A., Berg, A. O., & Morton, S. C. (2013) · Cited by 942

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

WRITING COMMITTEE MEMBERS, Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000435 · Cited by 897

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Anand, I. S., Fisher, L. D., Chiang, Y.-T., Latini, R., Masson, S., Maggioni, A. P., Glazer, R. D., Tognoni, G., & Cohn, J. N. (2003) · Circulation · doi:10.1161/01.cir.0000054164.99881.00 · Cited by 864

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

Dao, Q., Krishnaswamy, P., Kazanegra, R., Harrison, A., Amirnovin, R., Lenert, L., Clopton, P., Alberto, J., Hlavin, P., & Maisel, A. S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01156-6 · Cited by 816

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis

Lv, J., Neal, B., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S., Turnbull, F., Hillis, G., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001293 · Cited by 777

Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction: The Aldo-DHF Randomized Controlled Trial

Edelmann, F., Wachter, R., Schmidt, A. G., Kraigher-Krainer, E., Colantonio, C., Kamke, W., Duvinage, A., Stahrenberg, R., Durstewitz, K., Löffler, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.905 · Cited by 746

Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia

Bennett, C. L. (2008) · JAMA · doi:10.1001/jama.299.8.914 · Cited by 731

Cardiac Troponin and Outcome in Acute Heart Failure

Peacock, W. F., De Marco, T., Fonarow, G. C., Diercks, D., Wynne, J., Apple, F. S., & Wu, A. H. B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706824 · Cited by 730

N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients

Bettencourt, P., Azevedo, A., Pimenta, J., Friões, F., Ferreira, S., & Ferreira, A. (2004) · Circulation · doi:10.1161/01.cir.0000144310.04433.be · Cited by 729

B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure

Berger, R., Huelsman, M., Strecker, K., Bojic, A., Moser, P., Stanek, B., & Pacher, R. (2002) · Circulation · doi:10.1161/01.cir.0000016642.15031.34 · Cited by 706

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Packer, M., McMurray, J. J. V., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013748 · Cited by 673

Suppression of Central Sleep Apnea by Continuous Positive Airway Pressure and Transplant-Free Survival in Heart Failure: A Post Hoc Analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure Trial (CANPAP)

Arzt, M., Floras, J. S., Logan, A. G., Kimoff, R. J., Series, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.683482 · Cited by 669

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study

Cheng, V., Kazanagra, R., Garcia, A., Lenert, L., Krishnaswamy, P., Gardetto, N., Clopton, P., & Maisel, A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01157-8 · Cited by 668

Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure: The STOP-HF Randomized Trial

Ledwidge, M., Gallagher, J., Conlon, C., Tallon, E., O’Connell, E., Dawkins, I., Watson, C., O’Hanlon, R., Bermingham, M., Patle, A., et al. (2013) · JAMA · doi:10.1001/jama.2013.7588 · Cited by 664

BNP-Guided vs Symptom-Guided Heart Failure Therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial

Pfisterer, M., Buser, P., Rickli, H., Gutmann, M., Erne, P., Rickenbacher, P., Vuillomenet, A., Jeker, U., Dubach, P., Beer, H., et al. (2009) · JAMA · doi:10.1001/jama.2009.2 · Cited by 652

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

Konstam, M. A., Neaton, J. D., Dickstein, K., Drexler, H., Komajda, M., Martinez, F. A., Riegger, G. A., Malbecq, W., Smith, R. D., Guptha, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61913-9 · Cited by 646

Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure

Jourdain, P., Jondeau, G., Funck, F., Gueffet, P., Le Helloco, A., Donal, E., Aupetit, J. F., Aumont, M. C., Galinier, M., Eicher, J. C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.081 · Cited by 646

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

Silverberg, D. S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., Schwartz, D., Yachnin, T., Steinbruch, S., Shapira, I., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01248-7 · Cited by 644

Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)

Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J., Rouleau, J.-L., & Swedberg, K. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 621

ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31821daaf6 · Cited by 614

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., Givertz, M. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.011 · Cited by 613

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

Ruilope, L. M., Dukat, A., Böhm, M., Lacourcière, Y., Gong, J., & Lefkowitz, M. P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61966-8 · Cited by 599

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

de Boer, R. A., Lok, D. J. A., Jaarsma, T., van der Meer, P., Voors, A. A., Hillege, H. L., & van Veldhuisen, D. J. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.538080 · Cited by 592

Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

Swedberg, K., Young, J. B., Anand, I. S., Cheng, S., Desai, A. S., Diaz, R., Maggioni, A. P., McMurray, J. J. V., O'Connor, C., Pfeffer, M. A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214865 · Cited by 592

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure

Logeart, D., Thabut, G., Jourdain, P., Chavelas, C., Beyne, P., Beauvais, F., Bouvier, E., & Solal, A. C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.044 · Cited by 591

Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure

Horwich, T. B., Patel, J., MacLellan, W. R., & Fonarow, G. C. (2003) · Circulation · doi:10.1161/01.cir.0000084543.79097.34 · Cited by 590

Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community

Ho, J. E., Liu, C., Lyass, A., Courchesne, P., Pencina, M. J., Vasan, R. S., Larson, M. G., & Levy, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.053 · Cited by 589

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

Kostis, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.014 · Cited by 579

Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction

Redfield, M. M., Anstrom, K. J., Levine, J. A., Koepp, G. A., Borlaug, B. A., Chen, H. H., LeWinter, M. M., Joseph, S. M., Shah, S. J., Semigran, M. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510774 · Cited by 549

Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients

Bohlius, J., Wilson, J., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S., Djulbegovic, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 548

Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

Szczech, L. A., Barnhart, H. X., Inrig, J. K., Reddan, D. N., Sapp, S., Califf, R. M., Patel, U. D., & Singh, A. K. (2008) · Kidney International · doi:10.1038/ki.2008.295 · Cited by 526

Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea

Januzzi, J. L., Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O’Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.014 · Cited by 522

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines

Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 519

ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly

Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Ann Forciea, M., Frishman, W. H., Jaigobin, C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.008 · Cited by 514

Plasma brain natriuretic peptide in assessment of acute dyspnoea

Davis, M., Espiner, E. A., Yandle, T., Richards, G., Town, I., Neill, A., Drennan, C., Richards, A., Turner, J., & Billings, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92690-5 · Cited by 510

Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., & Ferrari, R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406430 · Cited by 486

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.129437 · Cited by 482

Impact of age and sex on plasma natriuretic peptide levels in healthy adults

Wang, T. J., Larson, M. G., Levy, D., Leip, E. P., Benjamin, E. J., Wilson, P. W. F., Sutherland, P., Omland, T., & Vasan, R. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02464-5 · Cited by 471

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction

van Veldhuisen, D. J., Cohen-Solal, A., Böhm, M., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J. S., Poole-Wilson, P. A., & Flather, M. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.046 · Cited by 468

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

Lok, D. J. A., Van Der Meer, P., de la Porte, P. W. B.-A., Lipsic, E., Van Wijngaarden, J., Hillege, H. L., & van Veldhuisen, D. J. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0125-y · Cited by 465

Troponin Elevation in Heart Failure

Kociol, R. D., Pang, P. S., Gheorghiade, M., Fonarow, G. C., O'Connor, C. M., & Felker, G. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.016 · Cited by 443

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.016 · Cited by 441

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT)

Maisel, A., Hollander, J. E., Guss, D., McCullough, P., Nowak, R., Green, G., Saltzberg, M., Ellison, S. R., Bhalla, M. A., Bhalla, V., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.015 · Cited by 431

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

Maeda, K., Tsutamoto, T., Wada, A., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00912-8 · Cited by 418

Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement

Anwaruddin, S., Lloyd-Jones, D. M., Baggish, A., Chen, A., Krauser, D., Tung, R., Chae, C., & Januzzi, J. L. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.051 · Cited by 410

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin

Richards, A. M., Doughty, R., Nicholls, M. G., MacMahon, S., Sharpe, N., Murphy, J., Espiner, E. A., Frampton, C., & Yandle, T. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01269-4 · Cited by 389

Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure

Rehman, S. U., Mueller, T., & Januzzi, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.042 · Cited by 386

PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)

Huelsmann, M., Neuhold, S., Resl, M., Strunk, G., Brath, H., Francesconi, C., Adlbrecht, C., Prager, R., Luger, A., Pacher, R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.069 · Cited by 385

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

Zile, M. R., Claggett, B. L., Prescott, M. F., McMurray, J. J. V., Packer, M., Rouleau, J. L., Swedberg, K., Desai, A. S., Gong, J., Shi, V. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.931 · Cited by 375

Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases: Form and Function

Shah, S. H., Kraus, W. E., & Newgard, C. B. (2012) · Circulation · doi:10.1161/circulationaha.111.060368 · Cited by 370

Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community

Costello-Boerrigter, L. C., Boerrigter, G., Redfield, M. M., Rodeheffer, R. J., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., Heublein, D. M., & Burnett, J. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.025 · Cited by 369

N-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure

Lainchbury, J. G., Troughton, R. W., Strangman, K. M., Frampton, C. M., Pilbrow, A., Yandle, T. G., Hamid, A. K., Nicholls, M. G., & Richards, A. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.095 · Cited by 352

Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials

Felker, G. M., Hasselblad, V., Hernandez, A. F., & O'Connor, C. M. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.018 · Cited by 334

Galectin-3, Cardiac Structure and Function, and Long-Term Mortality in Patients with Acutely Decompensated Heart Failure

Shah, R. V., Chen-Tournoux, A. A., Picard, M. H., van Kimmenade, R. R. J., & Januzzi, J. L. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq091 · Cited by 326

N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study

Moe, G. W., Howlett, J., Januzzi, J. L., & Zowall, H. (2007) · Circulation · doi:10.1161/circulationaha.106.666255 · Cited by 325

The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study

Zaphiriou, A., Robb, S., Murray-Thomas, T., Mendez, G., Fox, K., McDonagh, T., Hardman, S. M. C., Dargie, H. J., & Cowie, M. R. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.022 · Cited by 322

B-Type Natriuretic Peptide–Guided Heart Failure Therapy: A Meta-analysis

Porapakkham, P. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.35 · Cited by 319

Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis

Lv, J., Ehteshami, P., Sarnak, M. J., Tighiouart, H., Jun, M., Ninomiya, T., Foote, C., Rodgers, A., Zhang, H., Wang, H., et al. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121468 · Cited by 305

Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials

Thomopoulos, C., Parati, G., & Zanchetti, A. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000881 · Cited by 298 · cited 1×

Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure

Cheng, M.-L., Wang, C.-H., Shiao, M.-S., Liu, M.-H., Huang, Y.-Y., Huang, C.-Y., Mao, C.-T., Lin, J.-F., Ho, H.-Y., & Yang, N.-I. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.018 · Cited by 298

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Halperin, J. L., Levine, G. N., Al-Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000312 · Cited by 291

Effect of Propranolol Versus No Propranolol on Total Mortality Plus Nonfatal Myocardial Infarction in Older Patients with Prior Myocardial Infarction, Congestive Heart Failure, and Left Ventricular Ejection Fraction ≥40% Treated With Diuretics Plus Angiotensin-Converting Enzyme Inhibitors

Aronow, W. S., Ahn, C., & Kronzon, I. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00320-2 · Cited by 276

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

Troughton, R. W., Frampton, C. M., Brunner-La Rocca, H.-P., Pfisterer, M., Eurlings, L. W. M., Erntell, H., Persson, H., O'Connor, C. M., Moertl, D., Karlstrom, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu090 · Cited by 275

Prediction of Heart Failure Mortality in Emergent Care: A Cohort Study

Lee, D. S., Stitt, A., Austin, P. C., Stukel, T. A., Schull, M. J., Chong, A., Newton, G. E., Lee, J. S., & Tu, J. V. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00003 · Cited by 273

Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia

Ghali, J. K., Anand, I. S., Abraham, W. T., Fonarow, G. C., Greenberg, B., Krum, H., Massie, B. M., Wasserman, S. M., Trotman, M.-L., Sun, Y., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.698514 · Cited by 270

Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification

Bayes-Genis, A., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Barallat, J., Zamora, E., Urrutia, A., & Lupón, J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.087 · Cited by 259

Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

Eschalier, R., McMurray, J. J. V., Swedberg, K. B., van Veldhuisen, D. J., Krum, H., Pocock, S., Shi, H. H., Vincent, J., Rossignol, P., Zannad, F. M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.086 · Cited by 251

Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Holmqvist, F., Guan, N., Zhu, Z., Kowey, P. R., Allen, L. A., Fonarow, G. C., Hylek, E. M., Mahaffey, K. W., Freeman, J. V., Chang, P., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2014.12.024 · Cited by 249

C-Reactive Protein as a Predictor of Improvement and Readmission in Heart Failure

Alonso-Martínez, J. L., Llorente‐Diez, B., Agara, M. E., Preciado, F. O., Urbieta-Echezarreta, M. A., & Arencibia, C. G. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00021-1 · Cited by 243

Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims

Kociol, R. D., Horton, J. R., Fonarow, G. C., Reyes, E. M., Shaw, L. K., O'Connor, C. M., Felker, G. M., & Hernandez, A. F. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.962290 · Cited by 242

Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure

Gaggin, H. K., Szymonifka, J. D., Bhardwaj, A., Belcher, A. M., Berardinis, B. D., Motiwala, S. R., Wang, T. J., & Januzzi, J. L. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2013.10.005 · Cited by 241

Triage After Hospitalization With Advanced Heart Failure

O’Connor, C. M., Hasselblad, V., Mehta, R. H., Tasissa, G., Califf, R. M., Fiuzat, M., Rogers, J. G., Leier, C. V., & Stevenson, L. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.083 · Cited by 240

Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure

Tang, W. H. W., Girod, J. P., Lee, M. J., Starling, R. C., Young, J. B., Van Lente, F., & Francis, G. S. (2003) · Circulation · doi:10.1161/01.cir.0000106903.98196.b6 · Cited by 239

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

Lassus, J. P. E., Gayat, É., Mueller, C. E., Peacock, W. F., Špinar, J., Harjola, V., van Kimmenade, R. R. J., Pathak, A., Mueller, T., DiSomma, S., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.228 · Cited by 239

Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure

Neuhold, S., Huelsmann, M., Strunk, G., Stoiser, B., Struck, J., Morgenthaler, N. G., Bergmann, A., Moertl, D., Berger, R., & Pacher, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.050 · Cited by 236

N-Terminal Pro–B-Type Natriuretic Peptide–Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure

Berger, R., Moertl, D., Peter, S., Ahmadi, R., Huelsmann, M., Yamuti, S., Wagner, B., & Pacher, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.078 · Cited by 232

The Diagnostic Value of Physical Examination and Additional Testing in Primary Care Patients With Suspected Heart Failure

Kelder, J. C., Cramer, M. J., van Wijngaarden, J., van Tooren, R., Mosterd, A., Moons, K. G. M., Lammers, J. J., Cowie, M., Grobbee, D. E., & Hoes, A. W. (2011) · Circulation · doi:10.1161/circulationaha.111.019216 · Cited by 231

Relationship Between B-Type Natriuretic Peptides and Pulmonary Capillary Wedge Pressure in the Intensive Care Unit

Forfia, P. R., Watkins, S. P., Rame, J. E., Stewart, K. J., & Shapiro, E. P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.046 · Cited by 230

Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure

Masson, S., Anand, I. S., Favero, C., Barlera, S., Vago, T., Bertocchi, F., Maggioni, A. P., Tavazzi, L., Tognoni, G., Cohn, J. N., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.044149 · Cited by 226

Vasopeptidase inhibition and angio-oedema

Messerli, F. H., & Nussberger, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02596-4 · Cited by 225

AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions: From the American Heart Association, American College of Cardiology, and US Department of Health and Human Services

Arnett, D. K., Goodman, R. A., Halperin, J. L., Anderson, J. L., Parekh, A. K., & Zoghbi, W. A. (2014) · Circulation · doi:10.1161/cir.0000000000000128 · Cited by 220

Effect of Darbepoetin Alfa on Exercise Tolerance in Anemic Patients With Symptomatic Chronic Heart Failure

Ponikowski, P. P., Anker, S. D., Szachniewicz, J., Okonko, D. O., Ledwidge, M. T., Zymliński, R., Ryan, E., Wasserman, S. M., Baker, N. F., Rosser, D., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.024 · Cited by 210

Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction

Manzano-Fernández, S., Mueller, T., Pascual-Figal, D., Truong, Q. A., & Januzzi, J. L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.011 · Cited by 209

Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival

Tang, W. H. W., Shrestha, K., Shao, Z., Borowski, A. G., Troughton, R. W., Thomas, J. D., & Klein, A. L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.056 · Cited by 209

BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review

Santaguida, P. L., Don-Wauchope, A. C., Oremus, M., McKelvie, R., Ali, U., Hill, S. A., Balion, C., Booth, R. A., Brown, J. A., Bustamam, A., et al. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9442-y · Cited by 208

Multiple Biomarkers for Risk Prediction in Chronic Heart Failure

Ky, B., French, B. C., Levy, W. C., Sweitzer, N. K., Fang, J. C., Wu, A. H. B., Goldberg, L. R., Jessup, M. L., & Cappola, T. P. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.965020 · Cited by 205

Signature of Circulating microRNAs in Patients with Acute Heart Failure

Ovchinnikova, E. S., Schmitter, D., Vegter, E. L., ter Maaten, J. M., Valente, M. A. E., Liu, L. C. Y., van der Harst, P., Pinto, Y. M., de Boer, R. A., Meyer, S., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.332 · Cited by 196

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

van Veldhuisen, D. J., Dickstein, K., Solal, A. C., Lok, D. J. A., Wasserman, S. M., Baker, N. F., Rosser, D., Cleland, J. G. F., & Ponikowski, P. P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm328 · Cited by 194

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

Halperin, J. L., Levine, G. N., Al-Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.001 · Cited by 191

Associations Among Androgens, Estrogens, and Natriuretic Peptides in Young Women

Chang, A. Y., Abdullah, S. M., Jain, T., Stanek, H. G., Das, S. R., McGuire, D. K., Auchus, R. J., & de Lemos, J. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.040 · Cited by 189

Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets

Eurlings, L. W. M., van Pol, P. E. J., Kok, W. E., van Wijk, S., Lodewijks-van der Bolt, C., Balk, A. H. M. M., Lok, D. J. A., Crijns, H. J. G. M., van Kraaij, D. J. W., de Jonge, N., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.030 · Cited by 189

State of the Art: Newer Biomarkers in Heart Failure

de Boer, R. A., Daniels, L. B., Maisel, A. S., & Januzzi, J. L. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.273 · Cited by 188

The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Jacobs, A. K., Anderson, J. L., & Halperin, J. L. (2014) · Circulation · doi:10.1161/cir.0000000000000090 · Cited by 188

Circulating microRNAs in Heart Failure with Reduced and Preserved Left Ventricular Ejection Fraction

Wong, L. L., Armugam, A., Sepramaniam, S., Karolina, D. S., Lim, K. Y., Lim, J. Y., Chong, J. P. C., Ng, J. Y. X., Chen, Y.-T., Chan, M. M. Y., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.223 · Cited by 188

Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure

Kociol, R. D., McNulty, S. E., Hernandez, A. F., Lee, K. L., Redfield, M. M., Tracy, R. P., Braunwald, E., O’Connor, C. M., & Felker, G. M. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.969246 · Cited by 183

Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure

Vardeny, O., Miller, R., & Solomon, S. D. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.09.001 · Cited by 182

The Current Prevalence of Sleep Disordered Breathing in Congestive Heart Failure Patients Treated with Beta-Blockers

Macdonald, M., Fang, J., Pittman, S. D., White, D. P., & Malhotra, A. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27076 · Cited by 177

ACCF/AHA Clinical Practice Guideline Methodology Summit Report

Jacobs, A. K., Kushner, F. G., Ettinger, S. M., Guyton, R. A., Anderson, J. L., Ohman, E. M., Albert, N. M., Antman, E. M., Arnett, D. K., Bertolet, M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.025 · Cited by 175

Increasingly Sensitive Assays for Cardiac Troponins: A Review

de Lemos, J. A. (2013) · JAMA · doi:10.1001/jama.2013.5809 · Cited by 174

AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions

Arnett, D. K., Goodman, R. A., Halperin, J. L., Anderson, J. L., Parekh, A. K., & Zoghbi, W. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.012 · Cited by 167

Usefulness of B-Type Natriuretic Peptide and Cardiac Troponin Levels to Predict In-Hospital Mortality from ADHERE

Fonarow, G. C., Peacock, W. F., Horwich, T. B., Phillips, C. O., Givertz, M. M., Lopatin, M., & Wynne, J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.07.066 · Cited by 162

Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized Trials

Savarese, G., Trimarco, B., Dellegrottaglie, S., Prastaro, M., Gambardella, F., Rengo, G., Leosco, D., & Perrone-Filardi, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058287 · Cited by 161

The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure

Braunwald, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.033 · Cited by 155

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study

Cohn, J. N., Archibald, D., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W. S., Francis, G. S., Flohr, K. H., et al. (1987) · Survey of Anesthesiology · doi:10.1097/00132586-198702000-00050 · Cited by 155

The paradox of low BNP levels in obesity

Clerico, A., Giannoni, A., Vittorini, S., & Emdin, M. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9249-z · Cited by 148

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score

Salah, K., Kok, W. E. M., Eurlings, L. W. M., Bettencourt, P., Pimenta, J. M., Metra, M., Bayés‐Genís, A., Verdiani, V., Bettari, L., Lazzarini, V., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-303632 · Cited by 146

Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Sloan, S., Jarolím, P., Solomon, S. D., Pfeffer, M. A., & Braunwald, E. (2011) · Circulation · doi:10.1161/circulationaha.111.063842 · Cited by 144

Biomarkers of Myocardial Stress and Fibrosis as Predictors of Mode of Death in Patients With Chronic Heart Failure

Ahmad, T., Fiuzat, M., Neely, B., Neely, M. L., Pencina, M. J., Kraus, W. E., Zannad, F. M., Whellan, D. J., Donahue, M., Piña, I. L., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2013.12.004 · Cited by 139

Improved Pharmacological Therapy of Chronic Heart Failure in Primary Care: A Randomized Study of NT-proBNP Guided Management of Heart Failure – SIGNAL-HF (Swedish Intervention study – Guidelines and NT-proBNP AnaLysis in Heart Failure)

Persson, H., Erntell, H., Eriksson, B., Johansson, G., Swedberg, K. B., & Dahlström, U. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq169 · Cited by 137

The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide–Guided Therapy in Patients With Advanced Heart Failure

Shah, M., Califf, R. M., Nohria, A., Bhapkar, M. V., Bowers, M., MANCINI, D. M., Fiuzat, M., Stevenson, L. W., & O’Connor, C. M. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.04.012 · Cited by 136

Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence

Hill, S., Booth, R. A., Santaguida, P. L., Don-Wauchope, A., Brown, J. A., Oremus, M., Ali, U., Bustamam, A., Sohel, N., McKelvie, R. S., et al. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9447-6 · Cited by 133

Erythropoietin treatment in patients with chronic heart failure: a meta-analysis

van der Meer, P., Groenveld, H. F., Januzzi, J. L., & van Veldhuisen, D. J. (2009) · Heart · doi:10.1136/hrt.2008.161091 · Cited by 130

Pre-Discharge, But Not Admission, Levels of NT-Probnp Predict Adverse Prognosis Following Acute LVF

O’Brien, R. J., Squire, I. B., Demme, B., Davies, J. E., & Ng, L. L. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00098-9 · Cited by 126

Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart Failure

Solal, A. C., Logeart, D., Huang, B., Cai, D., Nieminen, M. S., & Mebazaa, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.058 · Cited by 123

Changes of Natriuretic Peptides Predict Hospital Admissions in Patients With Chronic Heart Failure

Savarese, G., Musella, F., D’Amore, C., Vassallo, E., Losco, T., Gambardella, F., Cecere, M., Petraglia, L., Pagano, G., Fimiani, L., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2013.11.007 · Cited by 121

ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel

Januzzi, J. L., Mebazaa, A., & Somma, S. D. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.037 · Cited by 118

Decision-making model for early diagnosis of congestive heart failure using rough set and decision tree approaches

Son, C., Kim, Y.-N., Kim, H., Park, H., & Kim, M. (2012) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2012.04.013 · Cited by 116

Charting a Roadmap for Heart Failure Biomarker Studies

Ahmad, T., Fiuzat, M., Pencina, M. J., Geller, N. L., Zannad, F. M., Cleland, J. G. F., Snider, J., Blankenberg, S., Adams, K. F., Redberg, R. F., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.02.005 · Cited by 113

Usefulness of Intermediate Amino-Terminal Pro-Brain Natriuretic Peptide Concentrations for Diagnosis and Prognosis of Acute Heart Failure

van Kimmenade, R. R. J., Pinto, Y. M., Bayés‐Genís, A., Lainchbury, J. G., Richards, M., & Januzzi, J. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.043 · Cited by 111

The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey

Jacobs, A. K., Anderson, J. L., & Halperin, J. L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.001 · Cited by 109

Brain Natriuretic Peptide-Guided Treatment does not Improve Morbidity and Mortality in Extensively Treated Patients with Chronic Heart Failure: Responders to Treatment have a Significantly Better Outcome

Karlström, P., Alehagen, U., Boman, K., & Dahlström, U. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr078 · Cited by 108

Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study

de Lemos, J. A., McGuire, D. K., Khera, A., Das, S. R., Murphy, S. A., Omland, T., & Drazner, M. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.017 · Cited by 103

Amino-Terminal Pro–B-Type Natriuretic Peptide Testing for the Diagnosis or Exclusion of Heart Failure in Patients with Acute Symptoms

Januzzi, J. L., Chen‐Tournoux, A., & Moe, G. W. P. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.017 · Cited by 101

Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review

Booth, R. A., Hill, S., Don-Wauchope, A., Santaguida, P. L., Oremus, M., McKelvie, R. S., Balion, C. M., Brown, J. A., Ali, U., Bustamam, A., et al. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9445-8 · Cited by 94

Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction

Goetze, J. P., Møgelvang, R., Maage, L., Scharling, H., Schnohr, P., Søgaard, P., Rehfeld, J. F., & Jensen, J. S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl406 · Cited by 94

NT-ProBNP Reduction Percentage During Admission for Acutely Decompensated Heart Failure Predicts Long-Term Cardiovascular Mortality

Bayés‐Genís, A., López, L., Zapico, E., Cotes, C., Santaló, M., Ordóñez‐Llanos, J., & Juan Cinca, A. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.04.006 · Cited by 93

Associations Between Metabolomic Compounds and Incident Heart Failure Among African Americans: The ARIC Study

Zheng, Y., Yu, B., Alexander, D. C., Manolio, T. A., Aguilar, D. A., Coresh, J., HEISS, G. M., Boerwinkle, E., & Nettleton, J. A. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt004 · Cited by 93

Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema

Woodard-Grice, A. V., Lucisano, A. C., Byrd, J. B., Stone, E. R., Simmons, W. H., & Brown, N. J. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833d3acb · Cited by 92

Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides

Ng, L. L., Loke, I. W., Davies, J. E., Geeranavar, S., Khunti, K. K., Stone, M. A., Chin, D. T., & Squire, I. B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.058 · Cited by 92

COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY VERSUS STRESS CARDIAC MAGNETIC RESONANCE FOR THE MANAGEMENT OF SYMPTOMATIC REVASCULARIZED PATIENTS: A COST EFFECTIVENESS STUDY (STRATEGY STUDY)

Pontone, G., Andreini, D., Guglielmo, M., Rota, C., Mushtaq, S., Baggiano, A., Beltrama, V., Solbiati, A., Guaricci, A. I., & Pepi, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(16)31573-x · Cited by 85

Clinical Significance of Cardiac Troponins I and T in Acute Heart Failure

Ilva, T., Lassus, J. P. E., Siirilä‐Waris, K., Melin, J., PEUHKURINEN, K. J., Pulkki, K. J., Nieminen, M. S., Mustonen, H. K., Porela, P., & Harjola, V. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.06.009 · Cited by 84

Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure

Zairis, M. N., Tsiaousis, G. Z., Georgilas, A. T., Makrygiannis, S. S., Adamopoulou, E. N., Handanis, S. M., Batika, P. C., Prekates, A. A., Velissaris, D., Kouris, N., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.017 · Cited by 82

Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials

Kotecha, D., Ngo, K., Walters, J. A., Manzano, L., Palazzuoli, A., & Flather, M. D. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.02.013 · Cited by 77

Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study

Gaggin, H. K., Mohammed, A. A., Bhardwaj, A., Rehman, S., Gregory, S. A., Weiner, R. B., Baggish, A. L., Moore, S. A., Semigran, M. J., & Januzzi, J. L. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.05.005 · Cited by 76

Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening

Xanthakis, V., Larson, M. G., Wollert, K. C., Aragam, J. R., Cheng, S. C., Ho, J. E., Coglianese, E. E., Levy, D. A., Colucci, W. S., Felker, G. M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000399 · Cited by 76

Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department

Dieplinger, B., Gegenhuber, A., Kaar, G., Poelz, W., Haltmayer, M., & Mueller, T. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.02.002 · Cited by 75

Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure

Miller, W. L., Hartman, K. A., Grill, D. E., Struck, J., Bergmann, A., & Jaffe, A. S. (2011) · Heart · doi:10.1136/heartjnl-2011-300823 · Cited by 72

ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Id, P. (2013) · Cited by 69

Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure

Tang, W. H. W., Wu, Y., Grodin, J. L., Hsu, A. P., Hernandez, A. F., Butler, J., Metra, M., Voors, A. A., Felker, G. M., Troughton, R. W., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.07.015 · Cited by 68

Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)

Böhm, M., Robertson, M., Ford, I., BORER, J. S., Michel Komajda, N., Kindermann, I., Maack, C., Lainščak, M., Swedberg, K. B., & Tavazzi, L. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.09.029 · Cited by 67

Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): A Randomized Controlled Trial of the Effect of Serial B-Type Natriuretic Peptide Testing on Patient Management

Singer, A. J., Birkhahn, R., Guss, D., Chandra, A. B., Miller, C. D., Tiffany, B. R., Levy, P. D., Dunne, R., Bastani, A., Thode, H. C., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.826685 · Cited by 58

Reduction in BNP Levels With Treatment of Decompensated Heart Failure and Future Clinical Events

Dhaliwal, A. S., Deswal, A. M., Pritchett, A. M., Aguilar, D. A., Kar, B., Souchek, J., & Bozkurt, B. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.11.007 · Cited by 56

Galectin 3 complements BNP in risk stratification in acute heart failure

Fermann, G. J., Lindsell, C. J., Storrow, A. B., Hart, K. W., Sperling, M. I., Roll, S., Weintraub, N. L., Miller, K. F., Maron, D. J., Naftilan, A. J., et al. (2012) · Biomarkers · doi:10.3109/1354750x.2012.719037 · Cited by 55

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862